Please login to the form below

Not currently logged in
Email:
Password:

cholesterol

This page shows the latest cholesterol news and features for those working in and with pharma, biotech and healthcare.

Novartis links up with NHS for speedy access to cholesterol drug inclisiran

Novartis links up with NHS for speedy access to cholesterol drug inclisiran

Novartis has teamed up with the UK’s NHS in a novel partnership which will see patients receive accelerated access to its groundbreaking cholesterol-lowering drug inclisiran. . ... statins. In phase 3 trials of the gene-silencing drug, inclisiran was

Latest news

More from news
Approximately 23 fully matching, plus 469 partially matching documents found.

Latest Intelligence

  • A roadmap to the successful treatment of Alzheimer’s disease A roadmap to the successful treatment of Alzheimer’s disease

    This would create a similar situation to cardiovascular disease where we use cholesterol as a biomarker and give statins in a preventative mode.

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    All of these new drugs are helping the company overcome the decline of its cholesterol drug Crestor.

  • Tools for the digital world Tools for the digital world

    One study showed that patients with uncontrolled hypertension and diabetes achieved significantly greater reduction in blood pressure (BP) and LDL cholesterol, and were more likely to reach their BP goal, than

  • Challenging times Challenging times

    continents. We surveyed 21, 300 research participants with a range of chronic diseases including but not limited to high blood pressure, high cholesterol, diabetes, asthma, heart conditions and cancer.

  • Pharma deals in September 2015 Pharma deals in September 2015

    Amgen's busy month (part 2). Following FDA approval for its novel PCSK9 treatment for “bad cholesterol”, Amgen is moving onto tackle dyslipidemia, an asymptomatic disease in which serum lipid levels ... Dezima's TA-8995 (phase 2b-complete), is an

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics